A TP63 mutation identified in a Han Chinese family with ectodermal dysplasia

• Published in: Archives of oral biology 2023-08, Vol.152, p.105731-105731, Article 105731
• Main Authors: Zhou, Xi, Zhang, Chengcheng, Fan, Liwen, Wu, Shanshan, Yao, Siyue, Wang, Lin, Zhong, Weijie, Ma, Lan, Pan, Yongchu
• Format: Article
• Language: English
• Subjects: Animals; East Asian People; Ectodermal dysplasia; Ectodermal Dysplasia - genetics; Ectodermal Dysplasia - pathology; Humans; Mice; Mutation; Mutation, Missense; Pedigree; Pedigree discovery; TP63; Transcription Factors - genetics; Tumor Suppressor Proteins - genetics; Whole-exome sequencing
• ISSN: 0003-9969; 1879-1506
• DOI: 10.1016/j.archoralbio.2023.105731

The purpose of this study was to identify a pathogenic mutation located in TP63 in a nuclear Han Chinese family. Whole-exome sequencing and Sanger sequencing were performed to identify candidate variants. The AlphaFold and PyMOL predicted the three-dimensional structure of the protein. Single-cell RNA-sequencing data and spatiotemporal transcriptomic atlas were used to generate the dissection of candidate gene expression at single-cell resolution. Significant genes (Pearson’s coefficient ≥0.8 and P A:p.Arg337Gln) was identified in the proband. This variant was predicted deleterious and likely to impair the local stability of the protein. In addition, single-cell RNA-sequencing indicated that TP63 was highly expressed in skin tissues. Furthermore, spatial transcriptome data of mice embryos showed TP63 was mainly enriched in the mucosal epithelium, thymus, epidermis, mesenchyme, and surface ectoderm. GO and KEGG pathway annotation analysis revealed that TP63 played a positive role in the process of ectoderm via the TGF-beta signaling pathway. The missense variant of TP63 (c.1010 G>A:p.Arg337Gln) was associated with ectodermal dysplasia. •A heterozygous missense variant at TP63 was associated with ectodermal dysplasia.•Individuals with TP63 variants showed variable traits with ectodermal dysplasia.•TP63 impacted ectodermal development via the TGF-beta signaling pathway.